6938 — Suzhou Ribo Life Science Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$11.49bn
- HK$11.57bn
- CNY142.63m
Annual cashflow statement for Suzhou Ribo Life Science Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -437 | -257 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 90.3 | 41.8 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 8.11 | 106 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -288 | -60.7 |
| Capital Expenditures | -40.6 | -23.4 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 16.2 | 2.71 |
| Sale of Business | ||
| Sale of Fixed Assets | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -24.5 | -20.7 |
| Financing Cash Flow Items | -14.5 | -15.1 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -4.77 | 39.5 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -314 | -42.4 |